Jing Chen, Bing-Jie Hu, Kai Zhao, Yun Luo, Hao-Feng Lin, Zheng-Li Shi.Development of A MERS-CoV Replicon Cell Line for Antiviral Screening .VIROLOGICA SINICA, 2021, 36(4): 730-735.doi: 10.1007/s12250-020-00341-z
Citation:
Jing Chen, Bing-Jie Hu, Kai Zhao, Yun Luo, Hao-Feng Lin, Zheng-Li Shi.
Development of A MERS-CoV Replicon Cell Line for Antiviral Screening .VIROLOGICA SINICA, 2021, 36(4)
: 730-735.
http://dx.doi.org/10.1007/s12250-020-00341-z
Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
-
Jing Chen
1,2
,
-
Bing-Jie Hu
1,2
,
-
Kai Zhao
1,2
,
-
Yun Luo
1,2
,
-
Hao-Feng Lin
1,2
,
-
Zheng-Li Shi
1
,,

-
1.
CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China
-
2.
University of Chinese Academy of Sciences, Beijing, 100049, China
-
Corresponding author:
Zheng-Li Shi, zlshi@wh.iov.cn, ORCID: http://orcid.org/0000-0001-8089-163X
-
-